S-0.1, r. 12 - Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery

Table of contents
Full text
chapter S-0.1, r. 12
Regulation respecting drugs that a midwife may prescribe or administer in the practice of midwifery
MIDWIVES — DRUGS
Midwives Act
(chapter S-0.1, s. 9, 1st par.).
S-0.1
September 1 2012
1. The drugs that a midwife may prescribe or administer are
(1)  the drugs for the mother listed in Schedule I, on the conditions, if applicable, determined in the Schedule; and
(2)  the drugs for the child listed in Schedule II, on the conditions determined in the Schedule.
O.C. 967-2008, s. 1.
2. (Omitted).
O.C. 967-2008, s. 2.
DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE MOTHER


Substances Specifications and conditions


Acetaminophen For use during the prenatal and postpartum
period


Acetaminophen and codeine Pharmaceutical form containing 325 mg or less
(in combination) of acetaminophen and 30 mg or less of codeine
per tablet
Limited quantity for a 2-day period


Acetaminophen, caffeine and Pharmaceutical form containing 300 mg or less
codeine (in combination) of acetaminophen, 15 mg or less of caffeine
and 8 mg or less of codeine per tablet
Limited quantity for a 2-day period


Alginic acid


Aluminum hydroxide and magnesium hydroxide


Ampicillin Pharmaceutical form for parenteral
administration in prophylaxis during the
prolonged rupture of membranes in asymptomatic
women or in prophylaxis in respect of
beta-hemolytic streptococcus


Betamethasone, clotrimazole and Pharmaceutical form for topical administration
mupirocin (in combination) in a concentration of 0.1% betamethasone, 10%
clotrimazole and 2% mupirocin for the
treatment of fungal infections on nipples of
breastfeeding women


Betamethasone, miconazole and Pharmaceutical form for topical administration
mupirocin (in combination) in a concentration of 0.1% betamethasone, 2%
miconazole and 2% mupirocin for the treatment
of fungal infections on nipples of
breastfeeding women


Calcium carbonate


Calcium gluconate Pharmaceutical form for parenteral
administration in a concentration of 10% as
antidote for magnesium sulphate while awaiting
transfer of clinical responsibility to a
physician


Carboprost tromethamine Pharmaceutical form for parenteral
administration in a concentration of 0.25 mg
in prophylaxis or if hemorrhage during the
immediate postpartum period and synthetic
oxytocin is ineffective


Clindamycin Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus, if allergy to
penicillin G


Clotrimazole Pharmaceutical forms for topical and vaginal
administration in a concentration of 1%


Dextrose Pharmaceutical form for parenteral infusion
administration in a concentration of 5%
Or
Pharmaceutical form for oral administration
for a glucose tolerance test


Dextrose and sodium chloride Pharmaceutical form for parenteral infusion
(in combination) administration in a concentration of 5%
dextrose and 0.45% sodium chloride


Diazepam Pharmaceutical form for rectal administration
for the treatment of seizures, if magnesium
sulphate is ineffective


Diphenhydramine hydrochloride Pharmaceutical form for parenteral
administration for the treatment of allergic
reactions, with or without anaphylactic
reaction, with no increased body temperature
or systemic illness


Docusate calcium Pharmaceutical form for oral administration
during the prenatal and postpartum period


Docusate sodium Pharmaceutical form for oral administration
during the prenatal and postpartum period


Doxylamine succinate and Pharmaceutical form containing 10 mg of
pyridoxine hydrochloride doxylamine succinate and 10 mg of pyridoxine
(in combination) hydrochloride per tablet


Epinephrine Presented in the form of auto-injector or
ampoule in a concentration of 1 mg/ml for the
emergency treatment of anaphylactic reactions


Ergonovine maleate Pharmaceutical form for parenteral
administration in prophylaxis or if hemorrhage
during the immediate postpartum period and
synthetic oxytocin is ineffective


Erythromycin Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus, if allergy to
penicillin G and resistance to clindamycin


Ferrous fumarate Pharmaceutical form for oral administration,
if intolerance to ferrous sulphate


Ferrous gluconate Pharmaceutical form for oral administration,
if intolerance to ferrous sulphate or ferrous
fumarate


Ferrous sulphate Pharmaceutical form for oral administration


Folic acid Pharmaceutical form for oral administration
during the prenatal period


Glycerin Pharmaceutical form for rectal administration


Hamamelis and glycerin Pharmaceutical form for topical administration
(in combination) in a concentration of 50% hamamelis


Human immunoglobulin Pharmaceutical form for parenteral
administration during the prenatal and
postpartum period


Hydrocortisone and zinc Pharmaceutical form for rectal administration
sulphate (in combination) in a concentration of 0.5% hydrocortisone and
0.5% zinc sulphate


Ibuprofen For use during the postpartum period


Lidocaine Pharmaceutical form for topical administration
in a concentration of 4% for action on vaginal
mucus while repairing minor lacerations
Or
Pharmaceutical form for parenteral
administration in a concentration of 1%


Lorazepam Pharmaceutical forms for oral and sublingual
administration for manual removal of the
placenta, if hemorrhage


Magnesium sulphate Pharmaceutical form for parenteral
administration for the treatment of seizures


Miconazole Pharmaceutical forms for topical and vaginal
administration during the prenatal period in a
concentration of 2%


Misoprostol Pharmaceutical forms for oral or rectal
administration if hemorrhage during the
immediate postpartum period or synthetic
oxytocin is ineffective or unavailable


MMR vaccine Pharmaceutical form for parenteral
administration during the postpartum period


Morphine Pharmaceutical form for parenteral
administration during the neonatal period in
prolonged latency in primiparous women and
during the postpartum period


Multivitamins and minerals


Nitroglycerin Pharmaceutical form for sublingual spray
administration if excessive uterine activity
with a non-reassuring fetal heart rate or
prolapsed cord


Penicillin G Pharmaceutical form for parenteral
administration in prophylaxis in respect of
beta-hemolytic streptococcus


Psyllium (mucilage) Pharmaceutical form for oral administration
during the prenatal and postpartum period


Ringer’s lactate Pharmaceutical form for parenteral infusion
administration for fluid replacement if
substantial postpartum loss of blood or if
hemorrhage


Sodium chloride Pharmaceutical form for parenteral infusion
administration in a concentration of 0.9% for
fluid replacement if substantial postpartum
loss of blood, if hemorrhage or for dilution


Sodium citrate/sodium lauryl Pharmaceutical form for rectal administration
sulfate


Synthetic oxytocin Pharmaceutical form for parenteral
administration in prophylaxis or if hemorrhage
during the immediate postpartum period


Terconazole Pharmaceutical forms for topical and vaginal
administration during the prenatal period in a
concentration of 0.4%, if clotrimazole and
miconazole are ineffective


Vitamin B6 Pharmaceutical form for oral administration
for the treatment of nausea during the
prenatal period


Vitamin B12 For use during the prenatal period


Vitamin D and calcium Pharmaceutical form for oral administration in
(in combination) prophylaxis

O.C. 967-2008, Sch. I.
DRUGS THAT A MIDWIFE MAY PRESCRIBE OR ADMINISTER TO THE CHILD


Substances Specifications and conditions


Ampicillin Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation


Epinephrine Pharmaceutical forms for parenteral and
endotracheal administration in a concentration
of 0.1 mg/ml during neonatal resuscitation


Erythromycin Pharmaceutical form for ophthalmic
administration in a concentration of 0.5% in
prophylaxis in newborns


Gentamicin Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation


Gentian violet Pharmaceutical form for topical
administration, in a water solution, in a
concentration of 1% or less


Hepatitis B immune globulin Pharmaceutical form for parenteral
administration


Hepatitis B vaccine Pharmaceutical form for parenteral
administration


Naloxone hydrochloride Pharmaceutical form for parenteral
administration in a concentration of 0.4 mg/ml
in newborns having an emergency condition


Nystatin Pharmaceutical form for oral administration,
presented in the form of a suspension for the
treatment of non-recurrent, non- resistant
oral mycosis


Penicillin G Pharmaceutical form for parenteral
administration in newborns having an emergency
condition and after a medical consultation


Sodium chloride Pharmaceutical form for parenteral infusion
administration in a concentration of 0.9% in
newborns having an emergency condition or for
dilution


Vitamin D Pharmaceutical form for oral administration in
breastfed infants


Vitamin K1 Pharmaceutical form for parenteral and
oral administration

O.C. 967-2008, Sch. II.
REFERENCES
O.C. 967-2008, 2008 G.O. 2, 5005